Rok 2022

• Differential expression profile between amygdala and blood during chronic lithium treatment in a rat model of depression – a pilot study

  Publikacja

  • K. Sakrajda
  • D. Szczepankiewicz
  • J. Nowakowska
  • P. Celichowski
  • E. Banach
  • P. Zakowicz
  • P. Kołodziejski
  • E. Pruszyńska-Oszmałek
  • J. Pawlak
  • A. Szczepankiewicz

  - ACTA NEUROBIOLOGIAE EXPERIMENTALIS - Rok 2022

  Lithium is a mood stabilizer widely used in the pharmacotherapy of bipolar disorder and treatment‑resistant depression. Taking into account dysregulated inflammatory activity in depression and the immunomodulatory role of lithium, we hypothesized that genes associated with inflammatory responses may be potential biomarkers of lithium action. We aimed to compare gene expression changes between the brain and the periphery after...

  Pełny tekst do pobrania w serwisie zewnętrznym